Dabur India Ltd (DABUR):企業の財務・戦略的SWOT分析

◆英語タイトル:Dabur India Ltd (DABUR) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA8012387
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月5日
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:消費財
◆販売価格オプション(消費税別)
Single UserUSD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Dabur India Ltd (DABUR) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Dabur India Ltd (Dabur) is a consumer goods company that offers products in the areas of hair care, oral care, Ayurveda-based health care, skin care, home care and foods. The company markets its products under five brands namely, Dabur, Vatika, Hajmola, Real and Fem. Dabur markets its products through carrying and forwarding (C&F) agents, distributors and retail outlets. It operates manufacturing units in Baddi, Pantnagar, Sahibabad, Jammu, Silvassa, Alwar, Katni, Narendrapur, Pithampur, Siliguri, Nashik and a foods manufacturing facility in Newai. The company has operations in the Middle East, Asia, Africa, and the Americas. Dabur is headquartered in Ghaziabad, Uttar Pradesh, India.

Dabur India Ltd Key Recent Developments

May 01,2017: Dabur re-appoints Anand C Burman as non-executive chairman
Jan 31,2017: Dabur Q3 net profit decreases
Dec 26,2016: Dabur receives ICSI National Award for Excellence in Corporate Governance
Nov 01,2016: Dabur India Q2 net profit up 5% at Rs 357.3 Crore
Oct 26,2016: Dabur India Q2 net profit increases

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Dabur India Ltd – Key Facts 5
Dabur India Ltd – Key Employees 6
Dabur India Ltd – Key Employee Biographies 7
Dabur India Ltd – Major Products and Services 8
Dabur India Ltd – History 10
Dabur India Ltd – Company Statement 13
Dabur India Ltd – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Affiliate 18
Joint Venture 18
Section 2 – Company Analysis 19
Dabur India Ltd – Business Description 19
Dabur India Ltd – Corporate Strategy 20
Dabur India Ltd – SWOT Analysis 21
SWOT Analysis – Overview 21
Dabur India Ltd – Strengths 21
Dabur India Ltd – Weaknesses 22
Dabur India Ltd – Opportunities 23
Dabur India Ltd – Threats 24
Dabur India Ltd – Key Competitors 25
Section 3 – Company Financial Ratios 26
Financial Ratios – Capital Market Ratios 26
Financial Ratios – Annual Ratios 27
Performance Chart 30
Financial Performance 30
Financial Ratios – Interim Ratios 31
Financial Ratios – Ratio Charts 32
Dabur India Ltd, Recent Deals Summary 33
Section 4 – Company’s Recent Developments 34
Jan 31, 2017: Dabur Q3 net profit decreases 34
Dec 26, 2016: Dabur receives ICSI National Award for Excellence in Corporate Governance 35
Nov 01, 2016: Dabur India Q2 net profit up 5% at Rs 357.3 Crore 36
Oct 26, 2016: Dabur India Q2 net profit increases 37
Jul 27, 2016: Dabur Q1 consolidated net profit up 11.8% at Rs 292.8 Crore 38
Apr 29, 2016: Dabur Q4 consolidated net profit Surges 16.6% at Rs 331.9 Cr 39
Jan 29, 2016: Dabur India Q3 net profit up 12.6% to Rs 318.5 Crore 40
Section 5 – Appendix 41
Methodology 41
Ratio Definitions 41
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
Dabur India Ltd, Key Facts 5
Dabur India Ltd, Key Employees 6
Dabur India Ltd, Key Employee Biographies 7
Dabur India Ltd, Major Products and Services 8
Dabur India Ltd, History 10
Dabur India Ltd, Other Locations 15
Dabur India Ltd, Subsidiaries 16
Dabur India Ltd, Affiliate 18
Dabur India Ltd, Joint Venture 18
Dabur India Ltd, Key Competitors 25
Dabur India Ltd, Ratios based on current share price 26
Dabur India Ltd, Annual Ratios 27
Dabur India Ltd, Annual Ratios (Cont...1) 28
Dabur India Ltd, Annual Ratios (Cont...2) 29
Dabur India Ltd, Interim Ratios 31
Dabur India Ltd, Recent Deals Summary 33
Currency Codes 41
Capital Market Ratios 41
Equity Ratios 42
Profitability Ratios 42
Cost Ratios 43
Liquidity Ratios 43
Leverage Ratios 44
Efficiency Ratios 44

★海外企業調査レポート[Dabur India Ltd (DABUR):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • EyeGate Pharmaceuticals Inc (EYEG):企業の財務・戦略的SWOT分析
    Summary EyeGate Pharmaceuticals Inc (EyeGate) is a clinical-stage specialty pharmaceutical and drug delivery company that develops and commercializes products for treating diseases and disorders of the eye. The company’s proprietary technology EyeGate II delivery system, utilizes transscleral iontop …
  • eBay Inc:戦略・SWOT・企業財務分析
    eBay Inc - Strategy, SWOT and Corporate Finance Report Summary eBay Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • CompuGroup Medical Deutschland AG (COP)-医療機器分野:企業M&A・提携分析
    Summary CompuGroup Medical Deutschland AG (CGM) is a provider of medical software products and healthcare services. The company's products comprise communication solutions, software assisted medicine, dentist information systems, ambulatory information systems, drug safety, patient marketing, and ot …
  • The Bank of Okinawa, Ltd. (8397):企業の財務・戦略的SWOT分析
    The Bank of Okinawa, Ltd. (8397) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Le Chateau Inc. (CTU):企業の財務・戦略的SWOT分析
    Le Chateau Inc. (CTU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • BioLamina AB:製薬・医療:M&Aディール及び事業提携情報
    Summary BioLamina AB (BioLamina) is a biotechnology company that focuses on the development, manufacture and distribution of cell culture reagents intended for culturing primary cells. The company offers a wide portfolio of chemically defined and xeno-free laminin proteins. Its product portfolio inc …
  • Bilfinger SE (GBF):石油・ガス:M&Aディール及び事業提携情報
    Summary Bilfinger SE (Bilfinger) is a provider of industrial engineering services. It offers a wide range of services from consulting, construction, manufacturing, plant expansion to maintenance and project management services across diverse end markets. The company’s major service offerings include …
  • Aerpio Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Aerpio Therapeutics Inc (Aerpio) is a biopharmaceutical company that develops novel monoclonal antibodies and small molecules. The company’s programs include a Tie-2 activator for diabetic macular edema and a hypoxia-inducible factor stabilizer for the treatment of inflammatory bowel disease …
  • TRACON Pharmaceuticals Inc (TCON):企業の財務・戦略的SWOT分析
    Summary TRACON Pharmaceuticals Inc (TRACON) is a biopharmaceutical company that develops and commercializes targeted therapies for cancer, age-related macular degeneration and fibrotic diseases. The company offers pipeline products such as TRC105, TRC102, TJ004309, TRC253, TRC694, and TRC205. Its le …
  • Allied Hotel Properties Inc.:戦略・SWOT・企業財務分析
    Allied Hotel Properties Inc. - Strategy, SWOT and Corporate Finance Report Summary Allied Hotel Properties Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Toyo Seikan Group Holdings, Ltd.
    Toyo Seikan Group Holdings, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Toyo Seikan Group Holdings, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • University of Oxford-製薬・医療分野:企業M&A・提携分析
    Summary University of Oxford (UO) is a research and educational university that offers student training, academic research and graduation programs. The university offers graduation courses in the various fields such as humanities, mathematical, physical and life sciences; medical sciences, and conti …
  • Teekay LNG Partners LP:企業のM&A・事業提携・投資動向
    Teekay LNG Partners LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Teekay LNG Partners LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • 3M Company:戦略・SWOT・企業財務分析
    3M Company - Strategy, SWOT and Corporate Finance Report Summary 3M Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Inditex SA (ITX):企業の財務・戦略的SWOT分析
    Inditex SA (ITX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Metro AG:企業の戦略・SWOT・財務情報
    Metro AG - Strategy, SWOT and Corporate Finance Report Summary Metro AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Senior Lifestyle Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Senior Lifestyle Corp (Senior Lifestyle) is a healthcare service provider that provides healthcare and resident services. The company owns and operates several senior living apartments and retirement communities. It provides life enrichment programs such as cultural and social activities, tr …
  • Medtronic Plc (MDT):医療機器:M&Aディール及び事業提携情報
    Summary Medtronic Plc (Medtronic), formerly Medtronic Inc, is a medical technology company that designs, develops, manufactures and markets a wide range of medical devices and solutions for the treatment of heart failure; heart valve disorders; diseases of the coronary artery; aortic; peripheral vas …
  • Spark Therapeutics Inc (ONCE):企業の財務・戦略的SWOT分析
    Summary Spark Therapeutics Inc (Spark) is a clinical-stage gene therapy company which provides gene therapies for inherited retinal diseases (IRDs), neurodegenerative diseases, as well as liver diseases. Its pipeline products include SPK-RPE65, SPK-CHM, rhonova, LHON, SPK-FIX, SPK-FVIII and SPK-TPP1 …
  • Valeant Canada LP-製薬・医療分野:企業M&A・提携分析
    Summary Valeant Canada LP (Valeant Canada), a subsidiary of Valeant Pharmaceuticals International Inc, is a pharmaceutical company that manufactures, markets and distributes pharmaceutical products. The company offers its products in various therapeutic areas, including pain management, neurology, c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆